Skip to main content
SpringerLink
Log in

Joint statement concerning retinopathy with hydroxychloroquine

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rosenbaum JT, et al. ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity. Arthritis and Rheumatology : 9 Feb 2021. Available from: URL: https://doi.org/10.1002/art.41683

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joint statement concerning retinopathy with hydroxychloroquine. Reactions Weekly 1846, 8 (2021). https://doi.org/10.1007/s40278-021-92256-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92256-x

Search

Navigation